131 related articles for article (PubMed ID: 8081875)
21. No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures.
Shahabuddin M; Sears JF; Khan AS
J Clin Microbiol; 2001 Feb; 39(2):675-84. PubMed ID: 11158127
[TBL] [Abstract][Full Text] [Related]
22. Use of helper cells with two host ranges to generate high-titer retroviral vectors.
Cosset FL; Girod A; Flamant F; Drynda A; Ronfort C; Valsesia S; Molina RM; Faure C; Nigon VM; Verdier G
Virology; 1993 Mar; 193(1):385-95. PubMed ID: 8382402
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of recombinant subgroup J avian leukosis viruses (ALV) expressing subgroup A ALV envelope.
Lupiani B; Hunt H; Silva R; Fadly A
Virology; 2000 Oct; 276(1):37-43. PubMed ID: 11021992
[TBL] [Abstract][Full Text] [Related]
24. Tissue tropism of the HPRS-103 strain of J subgroup avian leukosis virus and of a derivative acutely transforming virus.
Arshad SS; Howes K; Barron GS; Smith LM; Russell PH; Payne LN
Vet Pathol; 1997 Mar; 34(2):127-37. PubMed ID: 9066079
[TBL] [Abstract][Full Text] [Related]
25. Introduction of DT40 cells into chick embryos.
Toba M; Ebara F; Furuta H; Matsushimal Y; Kitagawa Y; Fujihara N
Asian J Androl; 2001 Mar; 3(1):49-53. PubMed ID: 11250794
[TBL] [Abstract][Full Text] [Related]
26. Influence of the nature of the reporter gene and selection pressure on stability of avian retrovirus vectors.
Molina RM; Legras C; Chebloune Y; Verdier G
C R Acad Sci III; 1995 Oct; 318(10):1021-7. PubMed ID: 8556447
[TBL] [Abstract][Full Text] [Related]
27. A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.
Seidler B; Schmidt A; Mayr U; Nakhai H; Schmid RM; Schneider G; Saur D
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10137-42. PubMed ID: 18621715
[TBL] [Abstract][Full Text] [Related]
28. Detection of avian leukosis virus subgroup J using the polymerase chain reaction.
Smith EJ; Williams SM; Fadly AM
Avian Dis; 1998; 42(2):375-80. PubMed ID: 9645329
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of three recombinant isolates of avian leukosis virus obtained from contaminated Marek's disease vaccines.
Barbosa T; Zavala G; Cheng S
Avian Dis; 2008 Jun; 52(2):245-52. PubMed ID: 18646453
[TBL] [Abstract][Full Text] [Related]
30. In vivo analysis of a new lacZ retrovirus vector suitable for cell lineage marking in avian and other species.
Mikawa T; Fischman DA; Dougherty JP; Brown AM
Exp Cell Res; 1991 Aug; 195(2):516-23. PubMed ID: 2070832
[TBL] [Abstract][Full Text] [Related]
31. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.
Valsesia-Wittmann S; Drynda A; Deléage G; Aumailley M; Heard JM; Danos O; Verdier G; Cosset FL
J Virol; 1994 Jul; 68(7):4609-19. PubMed ID: 8207835
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
33. Molecular indications for in vivo integration of the avian leukosis virus, subgroup J-long terminal repeat into the Marek's disease virus in experimentally dually-infected chickens.
Davidson I; Borenshtain R; Kung HJ; Witter RL
Virus Genes; 2002 Mar; 24(2):173-80. PubMed ID: 12018709
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of monoclonal antibodies to subgroup J avian leukosis virus.
Qin A; Lee LF; Fadly A; Hunt H; Cui Z
Avian Dis; 2001; 45(4):938-45. PubMed ID: 11785897
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients.
Hussain AI; Johnson JA; Da Silva Freire M; Heneine W
J Virol; 2003 Jan; 77(2):1105-11. PubMed ID: 12502826
[TBL] [Abstract][Full Text] [Related]
36. Characterization of endogenous avian leukosis viruses in chicken embryonic fibroblast substrates used in production of measles and mumps vaccines.
Johnson JA; Heneine W
J Virol; 2001 Apr; 75(8):3605-12. PubMed ID: 11264350
[TBL] [Abstract][Full Text] [Related]
37. Pathogenicity of avian leukosis viruses.
Okazaki W; Purchase HG; Crittenden LB
Avian Dis; 1982; 26(3):553-9. PubMed ID: 6293446
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of whole genome sequences and replication ability in cell cultures between two avian leukosis viruses of subgroup B].
Wu ZC; Zhu MZ; Bian XM; Ma CT; Zhao P; Cui ZZ
Bing Du Xue Bao; 2011 Sep; 27(5):447-55. PubMed ID: 21998957
[TBL] [Abstract][Full Text] [Related]
39. Molecular and biological characterization of a naturally occurring recombinant subgroup B avian leukosis virus with a subgroup J-like long terminal repeat.
Lupiani B; Pandiri AR; Mays J; Hunt HD; Fadly AM
Avian Dis; 2006 Dec; 50(4):572-8. PubMed ID: 17274296
[TBL] [Abstract][Full Text] [Related]
40. Use of reverse transcriptase polymerase chain reaction for detection of vaccine contamination by avian leukosis virus.
Häuptli D; Bruckner L; Ottiger HP
J Virol Methods; 1997 Jun; 66(1):71-81. PubMed ID: 9220392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
